VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,511,885 | -63.3% | 1,011,205 | -43.1% | 0.52% | -57.7% |
| Q2 2023 | $42,260,223 | -4.3% | 1,776,386 | +2.3% | 1.22% | -6.2% |
| Q1 2023 | $44,173,660 | +23.9% | 1,736,386 | +42.3% | 1.30% | +30.3% |
| Q4 2022 | $35,652,996 | +42.4% | 1,220,575 | 0.0% | 1.00% | +37.7% |
| Q3 2022 | $25,034,000 | +122.6% | 1,220,575 | +25.6% | 0.73% | +106.5% |
| Q2 2022 | $11,244,000 | -57.3% | 971,832 | -31.7% | 0.35% | -33.2% |
| Q1 2022 | $26,312,000 | -53.2% | 1,423,053 | -50.0% | 0.53% | +21.4% |
| Q4 2021 | $56,268,000 | +140.4% | 2,846,106 | +100.0% | 0.43% | +27.6% |
| Q3 2021 | $23,408,000 | -19.5% | 1,423,000 | -10.4% | 0.34% | +79.9% |
| Q2 2021 | $29,062,000 | – | 1,589,012 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |